PharmaTimes - October 2018

Women are increasingly making their voices heard in the industry, and female leaders across the sector are keen to show that pharma doesn’t have to be as male-dominated as it has traditionally been.

This month we have opinion articles from several key women leaders from different parts of the industry (p24). Together they make for a fascinating look not just at how workers at all levels can break down barriers to entry but also how more diversity can only be a win for pharma.

In this month’s features section we look at how pharma can harness design to improve its patient-centricity efforts (p22) and investigate some of the most interesting examples of AI in healthcare (p30). Meanwhile, on p20 EMIG chairman Leslie Galloway has some harsh words for the government on its treatment of the industry.

October 2018 - magazine highlights

A holistic approach to care

Steve How of Wilmington Healthcare explains how health and...

Women in pharma: Maria Belvisi

AstraZeneca's vice president and head, IMED Respiratory on...

AI has arrived

An in-depth look at the myriad ways artificial intelligenc...

Patient Files: 
Lupus and liver disease

At just 20 years old Kirsty Mills received a shock diagnos...

Life-changing by design

How harnessing design can help pharma connect with patient...

Women in pharma: Jill Larsen

Medidata's chief human resources officer on bringing women...

SmartPeople: 
Charlotte Chapman

BMS’ director, hub unit manager Regional Clinical Operatio...

The changing face of pharma sales

What a new commercial model to engage with HCPs should loo...